Lynne Murray, PhD, MBA
Lynne Murray brings experience in the discovery and development of pharmaceuticals from preclinical to Phase 2 in both large pharmaceutical and small biotech environments. Lynne joined our team from AstraZeneca where she was head of regeneration in their early respiratory & immunology department. Over her tenure at AZ she led multiple large and small molecule biology programs and worked in the partnering & strategy department at MedImmune/AZ following her MBA from Judge Business School of the University of Cambridge. Lynne was previously director of pharmacology at a U.S.-based biotech, Promedior. She holds a PhD in immunology and pathology from Imperial College London and is an author of numerous publications and patents.